HuGE Literature Finder
Records
1
-
8
| Correlation of circulating tumor DNA EGFR mutation levels with clinical outcomes in patients with advanced lung adenocarcinoma. Chinese medical journal 2021 Sep 134 (20): 2430-2437. Liu Xiang-Liang, Bai Ri-Lan, Chen Xiao, Zhao Yu-Guang, Wang Xu, Ma Ke-Wei, Tian Hui-Min, Han Fu-Jun, Liu Zi-Ling, Yang Lei, Li Wei, Gai Fei, Cui Jiu-W |
| Apatinib Monotherapy or Combination Therapy for Non-Small Cell Lung Cancer Patients With Brain Metastases. Oncology research 2019 Oct . Xu Jianping, Liu Xiaoyan, Yang Sheng, Shi Yuank |
| Clinical outcomes to pemetrexed-based versus non-pemetrexed-based platinum doublets in patients with KRAS-mutant advanced non-squamous non-small cell lung cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2019 Jul . Ricciuti B, Brambilla M, Cortellini A, De Giglio A, Ficorella C, Sidoni A, Bellezza G, Crinò L, Ludovini V, Baglivo S, Metro G, Chiari |
| Oncogenic driver mutations in Swiss never smoker patients with lung adenocarcinoma and correlation with clinicopathologic characteristics and outcome. PloS one 2019 14 (8): e0220691. Grosse Claudia, Soltermann Alex, Rechsteiner Markus, Grosse Alexand |
| Cytoplasmic expression of estrogen receptor ß may predict poor outcome of EGFR-TKI therapy in metastatic lung adenocarcinoma. Oncology letters 2018 Aug 16 (2): 2382-2390. Ding Xiaosheng, Li Li, Tang CHuanhao, Meng Chao, Xu Weiran, Wei Xing, Guo Ziwei, Zhang Tingting, Fu Yali, Zhang Lingling, Wang Xiangyi, Lin Li, Liang J |
| Lung cancer in never smokers from the Princess Margaret Cancer Centre. Oncotarget 2018 Apr 9 (32): 22559-22570. Korpanty Grzegorz J, Kamel-Reid Suzanne, Pintilie Melania, Hwang David M, Zer Alona, Liu Geoffrey, Leighl Natasha B, Feld Ronald, Siu Lillian L, Bedard Philippe L, Tsao Ming-Sound, Shepherd Frances |
| Standardized uptake value on (18)F-FDG-PET/CT is a predictor of EGFR T790M mutation status in patients with acquired resistance to EGFR-TKIs. Lung cancer (Amsterdam, Netherlands) 2016 Oct 100 14-9. Yoshida Tatsuya, Tanaka Hirotaka, Kuroda Hiroaki, Shimizu Junichi, Horio Yoshitsugu, Sakao Yukinori, Inaba Yoshitaka, Iwata Hiroshi, Hida Toyoaki, Yatabe Yasus |
| [Correlation between the efficacy of epidermal growth factor receptor tyrosine kinase inhibitors and EGFR mutations in advanced squamous cell lung cancer]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 2012 May 35 (5): 323-8. Duan Jian-chun, An Tong-tong, Wu Mei-na, Yang Lu, Bai Hua, Wang Zhi-jie, Wang Yu-yan, Zhuo Ming-lei, Zhao Jun, Wang Shu-hang, Wang J |
- Page last reviewed:Oct 1, 2021
- Page last updated:May 25, 2022
- Content source: